Rankings
▼
Calendar
ELAN Q1 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q1 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.3B
+2.5% YoY
Gross Profit
$629M
50.0% margin
Operating Income
$221M
17.6% margin
Net Income
$103M
8.2% margin
EPS (Diluted)
$0.21
QoQ Revenue Growth
+27.2%
Cash Flow
Operating Cash Flow
-$145M
Free Cash Flow
-$183M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$15.8B
Total Liabilities
$8.3B
Stockholders' Equity
$7.5B
Cash & Equivalents
$318M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.2B
+2.5%
Gross Profit
$629M
$580M
+8.4%
Operating Income
$221M
$176M
+25.6%
Net Income
$103M
$51M
+102.0%
Revenue Segments
Pet Health
$675M
38%
Farm Animal
$573M
32%
Cattle
$248M
14%
Poultry
$183M
10%
Swine
$102M
6%
Contract Manufacturing
$9M
1%
Geographic Segments
Non-US
$714M
57%
UNITED STATES
$543M
43%
← FY 2023
All Quarters
Q2 2023 →